Thermo Fisher Scientific (TMO) P/E (2008 - 2026)
Thermo Fisher Scientific (TMO) P/E from Jun 30, 2008 to Jul 21, 2026. The TTM Thermo Fisher Scientific (TMO) P/E is 30.83. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Thermo Fisher Scientific (TMO)
| Year | P/E | Change |
|---|---|---|
| 2026 | 30.83 | -10.57% |
| 2025 | 34.48 | +7.33% |
| 2024 | 32.12 | -8.69% |
| 2023 | 35.18 | +18.63% |
| 2022 | 29.66 | -9.79% |
| 2021 | 32.87 | -17.51% |
| 2020 | 39.85 | +4.19% |
| 2019 | 38.25 | +9.69% |
| 2018 | 34.87 | +1.48% |
| 2017 | 34.36 | +14.95% |
| 2016 | 29.89 | -2.55% |
| 2015 | 30.67 | +1.27% |
| 2014 | 30.29 | -7.80% |
| 2013 | 32.85 | +48.97% |
| 2012 | 22.05 | +66.18% |
| 2011 | 13.27 | -43.45% |
| 2010 | 23.46 | +5.38% |
| 2009 | 22.27 | -28.02% |
| 2008 | 30.94 | N/A |
Comparison Thermo Fisher Scientific (TMO) P/E with competitors
Thermo Fisher Scientific (TMO) P/E is 30.83.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -96.60% |
| MBAI | CheckCap Ltd | 1.71 | -94.45% |
| FONR | Fonar Corp | 15.48 | -49.80% |
| QGEN | Qiagen NV | 20.03 | -35.04% |
| DGX | Quest Diagnostics Inc | 22.47 | -27.11% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -22.58% |
| IQV | IQVIA Holdings Inc | 25.28 | -18.00% |
| A | Agilent Technologies Inc | 26.96 | -12.56% |
| MTD | Mettler-Toledo International Inc | 32.45 | +5.25% |
| MEDP | Medpace Holdings Inc | 32.55 | +5.57% |
| DHR | Danaher Corp | 38.55 | +25.04% |
| IDXX | Idexx Laboratories Inc | 40.58 | +31.60% |
| ILMN | Illumina Inc | 44.12 | +43.10% |
| RVTY | Revvity Inc | 52.68 | +70.86% |
| VCYT | Veracyte Inc | 53.71 | +74.21% |
| ICLR | Icon Plc | 57.45 | +86.34% |
| SHC | Sotera Health Company | 74.08 | +140.28% |
| WAT | Waters Corp | 102.79 | +233.37% |